A new drug promoting muscle growth may help counteract the significant lean body mass loss—up to 40%—associated with GLP-1-based slimming jabs like Wegovy and Mounjaro.
The research focused on the effects of apitegromab, a monoclonal antibody
Jun 09, 2026
01:19 pm
What's the storyA new muscle growth drug could help prevent the loss of lean body mass during weight loss, a study has found.
Lean body mass includes non-fat components such as muscles.
Muscle growth drug ‘could reduce loss of lean tissue’ when using slimming jabs
Muscle-boosting drug could help retain lean tissue when using weight-loss jabs
How a new drug could stop muscle-loss side effect of obesity jabs
Fat jab breakthrough as new drug could prevent dangerous muscle loss
Weight loss jabs 'should be probed as cancer prevention agents' after US study
Here’s how GLP-1 drugs could save your life, as well as make you slim
Here's how you can TRICK your body into thinking it's on fat jabs
Weight loss jabs linked to dramatic fall in obesity cancer risk
Encouraging trial results for AstraZeneca's new weight-loss pill
Popular Weight Loss Drugs Linked to Lower Risk of Breast Cancer
Trial suggests monoclonal antibody can help retain lean body mass when losing weight with GLP-1 medicines
Researchers found the use of a lab-made antibody can help retain lean body mass when using weight-loss jabs
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank…
An innovative drug could slash the risk of muscle loss for patients on weight loss, a new study has suggested.
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with…
Weight-loss injections, such as Wegovy and Mounjaro, have transformed how we treat obesity.
